Filing Flows › Viemed Healthcare (VMD) › Q3 2026 › vs Q2 2026
Viemed Healthcare (VMD) Q3 2026 vs Q2 2026 (quarter over quarter)
Viemed Healthcare's revenue rose $2.6M (+3%) from $78.1M in Q2 2026 to $80.7M in Q3 2026. Gross margin 57.3% against 57.7% (-0.4 pts).
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 57.3% | 57.7% | -0.4 pts |
| Operating margin | 8.6% | 5.7% | +2.9 pts |
| Net margin | 5.7% | 3.5% | +2.2 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $80.7M | $78.1M | $2.6M | +3% |
| Gross profit | $46.2M | $45.0M | $1.1M | +3% |
| Cost of revenue | $34.5M | $33.0M | $1.4M | +4% |
| Operating profit | $7.0M | $4.5M | $2.5M | +56% |
| Operating expenses | $39.2M | $40.6M | −$1.4M | -3% |
| Pre-tax earnings | $6.8M | $4.1M | $2.7M | +67% |
| Research & development | $501K | $504K | −$3K | -0.6% |
| SG&A | $35.5M | $37.1M | −$1.6M | -4% |
| Other operating costs | $3.2M | $3.0M | $270K | +9% |
| Net earnings | $4.6M | $2.8M | $1.9M | +68% |
| Minority interests | $99K | $136K | −$37K | -27% |
| Income tax | $2.0M | $1.2M | $897K | +78% |
| Depreciation & amortization | $7.7M | $7.5M | $198K | +3% |
| Share-based compensation | $2.5M | $2.0M | $444K | +22% |
| Working capital & other | $3.3M | −$3.6M | $6.9M | — |
| Operating cash flow | $11.5M | $15.9M | −$4.4M | -28% |
Questions
How much did Viemed Healthcare's revenue grow quarter over quarter in Q3 2026?
Viemed Healthcare's revenue rose $2.6M (+3%) from $78.1M in Q2 2026 to $80.7M in Q3 2026. Gross margin 57.3% against 57.7% (-0.4 pts).